🟡 60/100

Review before taking

  • Kava Kava: 425mg is 1.7× the Tolerable Upper Intake Level (250mg)
  • 100% of ingredients have research evidence
C Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Safety Alerts

⚠️ Kava Kava: 425mg is 1.7× the Tolerable Upper Intake Level (250mg)

The safety score is low because the 425mg dose of Kava Kava significantly exceeds the recommended maximum daily intake level of 250mg.

Label Data

1 Capsule(s) Serving Size
60 Servings
Botanical Product Type
100% Evidence Coverage

Supplement Facts — Evidence Check

425 mg
⚠️ Exceeds Tolerable Upper Intake Level by 1.7× (UL: 250 mg) 📚 12 studies (Tier A: 0, B: 5)
This product: 425mg UL 250mg

Other Ingredients

Microcrystalline Cellulose Magnesium Stearate Gelatin

Label Claims — Verification

All Other
Structure/Function
All Other (99% of products) Structure/Function (74% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

Directions: Take 1 or 2 capsules a day with meals.

⚠️ Warnings & Precautions

Excessive consumption may cause dizziness.

Keep out of the reach of children.

Do not use if safety seal is broken or missing.

🧪 Formulation Notes

The historical use of Kava in Polynesia confirms to be beneficial to help nervous tension, stress and agitation.

(Piper Methysticum)

A natural help for anxiety

Proudly Made in the USA.

Additional Information

Store in a cool dry place.

Proudly Made in the USA.

Product Details

UPC / SKU 7 89939 10070 7
DSLD Entry Date 2022-07-21
Product Type Botanical
Form Capsule
DSLD ID 271276
Data Updated 2026-04-11

Research Evidence

19 Research Sources
48 Avg Quality Score
8 Rct
5 Systematic Review
4 Meta Analysis
2 Clinical Trial
B Kava extract for treating anxiety
Meta Analysis The Cochrane database of systematic reviews 2003
B Kava for Generalized Anxiety Disorder: A Review of Current Evidence
Meta Analysis Journal of alternative and complementary medicine (New York, N.Y.) 2018
B Kava extract for treating anxiety
Systematic Review The Cochrane database of systematic reviews 2001
B Kava extract for treating anxiety
Systematic Review The Cochrane database of systematic reviews 2002
B The effectiveness and safety of Kava Kava for treating anxiety symptoms: A systematic review and analysis of randomized clinical trials
Systematic Review Complementary therapies in clinical practice 2018
C Kava for generalised anxiety disorder: A 16-week double-blind, randomised, placebo-controlled study
Rct The Australian and New Zealand journal of psychiatry 2020
C Kava and St. John's Wort: current evidence for use in mood and anxiety disorders
Systematic Review Journal of alternative and complementary medicine (New York, N.Y.) 2009
C Neuroimaging Insights: Kava's (Piper methysticum) Effect on Dorsal Anterior Cingulate Cortex GABA in Generalized Anxiety Disorder.
Rct Nutrients
C The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava
Meta Analysis Annals of internal medicine 2002
C Efficacy of kava extract for treating anxiety: systematic review and meta-analysis
Meta Analysis Journal of clinical psychopharmacology 2000
View all evidence for Kava →

Compare Similar Products

View all Kava products →